Stay updated on PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Sign up to get notified when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.

Latest updates to the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange Detected- Added revision v3.5.0 to the Study Record Versions. - Removed revision v3.4.3 from history.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer. This is a minor system update and does not alter study records or user workflows.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe page adds Revision: v3.4.2 and removes the government funding lapse notice and Revision: v3.4.1 from the history.SummaryDifference0.5%

- Check53 days agoChange DetectedA government funding status notice was added noting potential delays and that the NIH Clinical Center is open. The site revision was updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.5%

- Check60 days agoChange DetectedAdded a glossary display and color-coded highlights for record changes, and updated the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check74 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the previous entry v3.3.3 was removed.SummaryDifference0.1%

Stay in the know with updates to PHA-022121 Dose Study for Acute Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PHA-022121 Dose Study for Acute Angioedema Clinical Trial page.